Ellevest Inc
MRNA icon

Ellevest Inc’s Moderna MRNA Stock Holding History

Ellevest Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$413K Buy
+2,146
New +$231K 0.05% 278
2024
Q3 		– Sell
-2,293
Closed -$272K – 442
2024
Q2 		$272K Buy
2,293
+365
+19% +$46.2K 0.02% 331
2024
Q1 		$205K Buy
+1,928
New +$194K 0.01% 372
2023
Q2 		– Sell
-1,105
Closed -$170K – 1138
2023
Q1 		$170K Buy
1,105
+17
+2% +$2.8K 0.01% 347
2022
Q4 		$195K Buy
1,088
+363
+50% +$59.4K 0.02% 304
2022
Q3 		$86K Sell
725
-66
-8% -$10K 0.01% 452
2022
Q2 		$113K Buy
791
+48
+6% +$6.86K 0.01% 387
2022
Q1 		$128K Buy
743
+240
+48% +$40.4K 0.01% 371
2021
Q4 		$128K Buy
503
+482
+2,295% +$141K 0.01% 357
2021
Q3 		$8K Buy
+21
New +$7.74K ﹤0.01% 867
2020
Q3 		– Sell
-25
Closed -$2K – 1246
2020
Q2 		$2K Sell
25
-11
-31% -$602 ﹤0.01% 897
2020
Q1 		$1K Sell
36
-12
-25% -$276 ﹤0.01% 931
2019
Q4 		$1K Buy
+48
New +$852 ﹤0.01% 823

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Ellevest Inc's MRNA Position: Q3 2026 in Review

Ellevest Inc opened a new position in Moderna (MRNA) in Q3 2026: 2,146 shares worth $413K. The stake represents 0.05% of the portfolio and ranks #278 among its holdings. This is a return to the name: Ellevest Inc previously reported a position in MRNA as recently as Q2 2024.

Ellevest Inc first reported a position in MRNA in Q4 2019 and has held it in 13 quarters since. 633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Ellevest Inc held 2,146 shares of Moderna worth $413K as of Q3 2026.
  • Moderna was a new Ellevest Inc position in Q3 2026.
  • Moderna made up 0.05% of Ellevest Inc's portfolio in Q3 2026, its #278 holding.
  • Ellevest Inc first reported a position in Moderna in Q4 2019 and has held it in 13 quarters since.
  • 633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Ellevest Inc's 13F filing for Q3 2026, filed 10 Nov 2026.